Related Experiment Video
Updated: Apr 6, 2026
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
Loss-of-Function Screening in Hematopoietic Malignancies
1Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139.
Abstract:
Loss-of-function screens can be performed in vivo using retrovirally modified tumor cells. This approach has been used for decades in viral insertional mutagenesis to identify proto-oncogenes. In this approach, tumors are infected with a library of retroviral vectors expressing short-hairpin RNAs (shRNAs), such that each cell receives only a single retroviral insertion, and the representation of proviruses is monitored during ongoing tumor growth or before and after cancer therapy. The resulting tumors are highly chimeric, allowing a large diversity of loss-of-function phenotypes to be monitored simultaneously in an unbiased manner. This approach, used in conjunction with RNAi, can identify genes that are essential for the growth of diverse malignancies in vivo. Here, we outline this approach and discuss key challenges in performing these studies.
Insights
Loss-of-function screens using retrovirally modified tumor cells and short-hairpin RNAs (shRNAs) can identify genes critical for cancer growth in vivo. This unbiased approach enables simultaneous monitoring of diverse genetic effects in chimeric tumors.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Loss-of-function screens are crucial for identifying genes essential for biological processes.
- Viral insertional mutagenesis has historically been used to discover proto-oncogenes.
- RNA interference (RNAi) combined with retroviral vectors offers a powerful tool for genetic screens.
Purpose of the Study:
- To outline an in vivo loss-of-function screening approach using retrovirally modified tumor cells.
- To demonstrate the utility of short-hairpin RNAs (shRNAs) for identifying cancer-essential genes.
- To discuss the advantages and challenges of this screening methodology in cancer research.
Main Methods:
- Infection of tumors with retroviral vectors encoding a library of short-hairpin RNAs (shRNAs).
- Ensuring single proviral insertion per cell for accurate genetic perturbation.
- Monitoring proviral representation in chimeric tumors during growth or therapy.
- Utilizing RNA interference (RNAi) to induce gene silencing.
Main Results:
- Identification of genes essential for the growth of diverse malignancies in vivo.
- Demonstration of highly chimeric tumors allowing simultaneous monitoring of multiple loss-of-function phenotypes.
- Unbiased discovery of critical genes through large-scale screening.
Conclusions:
- Retroviral-mediated shRNA loss-of-function screens are effective for identifying cancer-driving genes in vivo.
- This approach provides an unbiased and comprehensive method for functional genomics in complex biological systems.
- Further optimization of these screens can enhance the discovery of therapeutic targets for various cancers.
More Related Videos
Related Concept Videos
02:46Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
01:12Loss of Tumor Suppressor Gene Functions